Global Chronic Urticaria Or Hives Drug Market Study 2016-2026, by Segment (GDC-0853, GSK-2646264, … …), by Market (Clinic, Hospital, … …), by Company (AstraZeneca Plc, Biofrontera AG, … …)
Table of Content
1 Industry Overview
- 1.1 Chronic Urticaria Or Hives Drug Industry
- 1.1.1 Overview
- 1.1.2 Products of Major Companies
- 1.2 Market Segment
- 1.2.1 Industry Chain
- 1.2.2 Consumer Distribution
- 1.3 Price & Cost Overview
2 Chronic Urticaria Or Hives Drug Market by Type
- 2.1 By Type
- 2.1.1 GDC-0853
- 2.1.2 GSK-2646264
- 2.1.3 BF-Derm-1
- 2.1.4 Bilastine
- 2.1.5 Others
- 2.2 Market Size by Type
- 2.3 Market Forecast by Type
3 Global Market Demand
- 3.1 Segment Overview
- 3.1.1 Clinic
- 3.1.2 Hospital
- 3.1.3 Others
- 3.2 Market Size by Demand
- 3.3 Market Forecast by Demand
4 Major Region Market
- 4.1 Global Market Overview
- 4.1.1 Market Size & Growth
- 4.1.2 Market Forecast
- 4.2 Major Region
- 4.2.1 Market Size & Growth
- 4.2.2 Market Forecast
5 Major Companies List
- 5.1 AstraZeneca Plc (Company Profile, Sales Data etc.)
- 5.2 Biofrontera AG (Company Profile, Sales Data etc.)
- 5.3 ELORAC, Inc. (Company Profile, Sales Data etc.)
- 5.4 Faes Farma, SA (Company Profile, Sales Data etc.)
- 5.5 Genentech, Inc. (Company Profile, Sales Data etc.)
- 5.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
- 5.7 J Uriach Y Compania, S.A. (Company Profile, Sales Data etc.)
- 5.8 Mabtech Limited (Company Profile, Sales Data etc.)
- 5.9 Merck & Co., Inc. (Company Profile, Sales Data etc.)
- 5.10 Mycenax Biotech Inc. (Company Profile, Sales Data etc.)
- 5.11 Novartis AG (Company Profile, Sales Data etc.)
- 5.12 Panacea Biotec Limited (Company Profile, Sales Data etc.)
6 Conclusion
List of Tables
List of Table
Table Global Chronic Urticaria Or Hives Drug Market 2016-2019, by Type, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market 2016-2019, by Type, in Volume
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, by Type, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, by Type, in Volume
Table Global Chronic Urticaria Or Hives Drug Demand 2016-2019, in USD Million
Table Global Chronic Urticaria Or Hives Drug Demand 2016-2019, in Volume
Table Global Chronic Urticaria Or Hives Drug Demand Forecast 2020-2026, in USD Million
Table Global Chronic Urticaria Or Hives Drug Demand Forecast 2020-2026, in Volume
Table Global Chronic Urticaria Or Hives Drug Market Size & Growth 2016-2019, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market Size & Growth 2016-2019, in Volume
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, in Volume
Table Global Chronic Urticaria Or Hives Drug Market 2016-2019, by Region, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market 2016-2019, by Region, in Volume
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, by Region, in USD Million
Table Global Chronic Urticaria Or Hives Drug Market Forecast 2020-2026, by Region, in Volume
Table AstraZeneca Plc Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Plc Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biofrontera AG Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Biofrontera AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ELORAC, Inc. Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of ELORAC, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Faes Farma, SA Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Faes Farma, SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genentech, Inc. Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Genentech, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table J Uriach Y Compania, S.A. Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of J Uriach Y Compania, S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mabtech Limited Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Mabtech Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mycenax Biotech Inc. Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Mycenax Biotech Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Panacea Biotec Limited Overview List
Table Chronic Urticaria Or Hives Drug Business Operation of Panacea Biotec Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
List of Figures
List of Figure
Figure Global Chronic Urticaria Or Hives Drug Market Growth 2016-2019, by Type, in USD Million
Figure Global Chronic Urticaria Or Hives Drug Market Growth 2016-2019, by Type, in Volume
Summary
The global Chronic Urticaria Or Hives Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinic
Hospital
Others
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa